Axsome Therapeutics (AXSM) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -11.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.19% |
| Dec 31, 2025 | 239.53% |
| Sep 30, 2025 | 26.37% |
| Jun 30, 2025 | 52.96% |
| Mar 31, 2025 | 15.30% |
| Dec 31, 2024 | 26.11% |
| Sep 30, 2024 | -0.81% |
| Jun 30, 2024 | -19.97% |
| Mar 31, 2024 | -955.46% |
| Dec 31, 2023 | -64.01% |
| Sep 30, 2023 | -46.47% |
| Jun 30, 2023 | -66.04% |
| Mar 31, 2023 | 83.35% |
| Dec 31, 2022 | -83.75% |
| Sep 30, 2022 | -26.95% |
| Jun 30, 2022 | -27.01% |
| Mar 31, 2022 | -37.51% |
| Dec 31, 2021 | -17.53% |
| Sep 30, 2021 | -58.13% |
| Jun 30, 2021 | -73.51% |
| Mar 31, 2021 | 14.30% |
| Dec 31, 2020 | -13.57% |
| Sep 30, 2020 | -11.50% |
| Jun 30, 2020 | -32.20% |
| Mar 31, 2020 | -211.77% |
| Dec 31, 2019 | -358.49% |
| Sep 30, 2019 | -129.85% |
| Jun 30, 2019 | -68.32% |
| Mar 31, 2019 | -45.49% |
| Dec 31, 2018 | 46.65% |
| Sep 30, 2018 | -230.90% |
| Jun 30, 2018 | -218.35% |
| Mar 31, 2018 | -193.37% |
| Dec 31, 2017 | -15.49% |
| Sep 30, 2017 | -12.63% |
| Jun 30, 2017 | -1.12% |
| Mar 31, 2017 | 30.41% |
| Dec 31, 2016 | 141.73% |
| Sep 30, 2016 | 256.15% |
| Jun 30, 2016 | 227.48% |
| Mar 31, 2016 | 204.32% |